7/25/2008

Horizon Therapeutics appointed Timothy P. Walbert as its new president and CEO. Walbert's long experience in the pharmaceutical and biotech industries will help the company launch HZT-501 -- a single-pill combination of famotidine and a proprietary formulation of ibuprofen, Horizon founder Dr. George Tidmarsh said.

Related Summaries